Benjamin Colvard, MD
- Medical Director, Vascular Surgery, UH Elyria Medical Center
- Specialty: Vascular Surgery
-
Location:UH Amherst Health Center
254 Cleveland Ave
Amherst, OH 44001
- Call: 440-414-9200
Biography: Benjamin Colvard, MD
Expertise
Certifications & Memberships
- Vascular Surgery - American Board of Surgery
Education
Fellowship | Surgical Innovation
Surgical Innovation - IHU Strasbourg - Institut De Chirurgie Guidée Par L’Image (2015 - 2017)
Residency | Vascular Surgery
Vascular Surgery - Stanford Hospital And Clinics (2012 - 2019)
Medical Education
Baylor College Of Medicine (2012)
Undergraduate
University Of Texas At Austin (2008)
About
Benjamin Colvard, MD, is a board-certified vascular surgeon at University Hospitals Harrington Heart & Vascular Institute and an Assistant Professor of Surgery at Case Western Reserve University School of Medicine.
Dr. Colvard is a University of Texas at Austin graduate, earning his medical degree from Baylor College of Medicine in Houston, Texas. He completed his vascular surgery residency at Stanford University, and a Surgical Innovations fellowship at the Institut Hospitalo-Universitaire in Strasbourg, France, before joining the staff at University Hospitals Cleveland Medical Center.
Dr. Colvard is skilled in both endovascular and open surgical techniques, as well as medical management of vascular pathologies. He has particular interest in endovascular aortic repair, especially in thoracoabdominal aneurysm disease and peripheral vascular disease. He is also actively involved in research to better understand the clinical outcomes of vascular and endovascular therapies.
Dr. Colvard has contributed to more than 20 publications in national peer reviewed journals on various topics related to vascular surgery and endovascular therapies. He is an active member of the Society of Vascular Surgeons.
Featured Videos
Watch to find out more about this University Hospitals provider.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Benjamin Colvard did not disclose any Outside Relationships with Industry.